Lords Mark Industries Ltd. Solidifies Global Footprint; Targets Export more than 6.55 Million Diagnostic Supplies to SAARC Countries

January 17, 2024 11:31 PM IST | By NewsVoir
 Lords Mark Industries Ltd. Solidifies Global Footprint; Targets Export more than 6.55 Million Diagnostic Supplies to SAARC Countries
Image source: NewsVoir

With the recent launch of Export Division for diagnostic supplies by LordsMed, the global healthcare division of Lord's Mark Industries Ltd. is set to export more than 6.55 Million diagnostic supplies in SAARC countries. LordsMed has successfully exported an impressive over 4.55 million diagnostic supplies, with plans to further enhance this figure by an additional over 2 million by the end of the current month. The company aims to establish itself as a leading global player in In-Vitro Diagnostics (IVD) manufacturing and export.

With a strong commitment to delivering quality IVD solutions at a reduced cost, Lords Med has successfully built a vast network of over 300 distributor channels across India. The manufacturing facilities located in the outskirts of Mumbai, currently has the capacity to facilitate more than 1.7 crore diagnostic tests per month, covering a wide range of specialties including biochemistry, haematology, serology, rapid tests, and urine strip tests.

Mr. Manav Teli, Executive Director, Lord's Mark Industries Ltd.

Commenting on the launch, Mr. Manav Teli, Executive Director, Lord's Mark Industries Ltd. said, "We are thrilled to announce our presence across borders with successful export of diagnostic supplies int Nepal and Bangladesh. Our goal has always been to emerge as a global leader in IVD manufacturing and export, providing top-quality solutions at an affordable cost. With our advanced manufacturing facilities and extensive distributor network, we are now expanding our reach to neighbouring countries. This marks a significant milestone in our journey towards meeting the healthcare needs of a wider population. We are also excited to explore OEM opportunities and further scale up our manufacturing capacity, ensuring accessible diagnostics for all."

As Lord's Mark Industries continues to strengthen its presence in the Indian market, the company is now strategically focusing on supplying neighbouring countries with its high-quality IVD products. The conglomerate currently has five companies: Lords Med, Lord's Mark Biotech, Lord's Mark Micro-biotech, Brahamastra Defense Techno Products Limited, Lord's Mark Insurance Broking Limited, and Lord's Automative Private Limited, with other verticals in renewable energy products and paper.

About Lord's Mark Industries
Incorporated in 1998, Lord's Mark Industries Private Ltd. (Lord's) has made impressive growth starting from paper to LED to Renewable energy and making grand in the medical diagnostic industry. Lord's and its subsidiaries have made a mark in Electric Vehicle, Genome Testing, Vitamin Industry and Healthcare. Growth through diversification has become the trend setter and has been the cornerstone of success at Lord's.

Website - lordsmark.com.

About LordsMed

LordsMed, the global healthcare division of Lords Mark Industries Pvt. Ltd, aims to become an integrated healthcare provider offering quality products in verticals encompassing therapeutic care (chronic & acute), hygiene care, pharma distribution, diagnostics and safety essentials. Lords Med is a manufacturer of In- Vitro Diagnostic test kits, Semi Autoanalyzer, Haematology machines, Rapid kits, Biochemistry Reagents k and Special Parameter used mostly by all government organisations, hospital (public and private) and labs via 400 plus strong distribution network Pan India. Lords Med is a manufacturer of in vitro diagnostic kits for COVID-19 (antigen and antibody), malaria and dengue. It is an authorized distributor partner of medical devices like health tracking. The division has more than 60 registered brands across chronic & acute care. Our R&D research team is constantly under development of new and unique products which can be useful to the public. lordsmed.com.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.